• A Z Zeman, D Kidd, B N McLean, M A Kelly, D A Francis, D H Miller, B E Kendall, P Rudge, E J Thompson, and W I McDonald.
• Institute of Neurology, University of London, UK.
• J. Neurol. Neurosurg. Psychiatr. 1996 Jan 1; 60 (1): 273027-30.

ObjectivesTo determine whether oligoclonal band (OCB) negative multiple sclerosis is a reliable diagnosis and, if so, whether it has a distinctive prognosis.MethodsRetrospective and matched prospective comparison of the clinical and laboratory features of patients with clinical definite multiple sclerosis with and without intrathecal synthesis of oligoclonal IgG.ResultsThirty four patients were identified with apparent OCB negative clinically definite multiple sclerosis. The results of oligoclonal banding proved to have been equivocal in 14 of 34; the clinical diagnosis of multiple sclerosis was questionable in 8 of 34. The remaining 12 patients with "true" OCB negative multiple sclerosis were significantly less disabled than matched OCB positive controls. Re-examination of CSF-serum pairs from six OCB negative patients showed that three remained OCB negative while three showed evidence of intrathecal synthesis of OCBs.ConclusionsOCB negative clinically definite multiple sclerosis is rare and should be diagnosed with caution; in unequivocal cases it seems to have a relatively benign prognosis.

20 keywords...

hide…